[go: up one dir, main page]

KR910700344A - HIV protein expression in Drosophila cells - Google Patents

HIV protein expression in Drosophila cells

Info

Publication number
KR910700344A
KR910700344A KR1019900701678A KR900701678A KR910700344A KR 910700344 A KR910700344 A KR 910700344A KR 1019900701678 A KR1019900701678 A KR 1019900701678A KR 900701678 A KR900701678 A KR 900701678A KR 910700344 A KR910700344 A KR 910700344A
Authority
KR
South Korea
Prior art keywords
protein expression
drosophila cells
hiv protein
hiv
drosophila
Prior art date
Application number
KR1019900701678A
Other languages
Korean (ko)
Other versions
KR0152525B1 (en
Inventor
란취 요한센 하네
로젠베르그 마틴
Original Assignee
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스미스클라인 비참 코포레이션 filed Critical 스미스클라인 비참 코포레이션
Publication of KR910700344A publication Critical patent/KR910700344A/en
Application granted granted Critical
Publication of KR0152525B1 publication Critical patent/KR0152525B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/75Vector systems having a special element relevant for transcription from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019900701678A 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells KR0152525B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27838688A 1988-12-01 1988-12-01
US7/278,386 1988-12-01
PCT/US1989/005155 WO1990006358A1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells

Publications (2)

Publication Number Publication Date
KR910700344A true KR910700344A (en) 1991-03-14
KR0152525B1 KR0152525B1 (en) 1998-10-01

Family

ID=23064787

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701678A KR0152525B1 (en) 1988-12-01 1989-11-29 Expression of hiv proteins in drosophila cells

Country Status (12)

Country Link
EP (1) EP0446272A4 (en)
JP (1) JP3085704B2 (en)
KR (1) KR0152525B1 (en)
AU (1) AU630649B2 (en)
CA (1) CA2003794C (en)
DK (1) DK175461B1 (en)
FI (1) FI113475B (en)
IL (1) IL92470A (en)
NO (1) NO314090B1 (en)
PT (1) PT92477A (en)
WO (1) WO1990006358A1 (en)
ZA (1) ZA899150B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2841376C (en) * 2011-07-05 2023-02-28 Duke University N-terminal deleted gp120 immunogens
WO2013052095A2 (en) 2011-10-03 2013-04-11 Duke University Vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
KR910700352A (en) * 1988-12-21 1991-03-14 스미스클라인 바이올로지칼즈(s.a.) Expression of Plasmodium Circus Sporozoite Protein in Insect Cells

Also Published As

Publication number Publication date
EP0446272A1 (en) 1991-09-18
AU4755290A (en) 1990-06-26
CA2003794A1 (en) 1990-06-01
WO1990006358A1 (en) 1990-06-14
PT92477A (en) 1990-06-29
NO912099D0 (en) 1991-05-31
AU630649B2 (en) 1992-11-05
EP0446272A4 (en) 1993-01-07
CA2003794C (en) 2000-02-08
NO314090B1 (en) 2003-01-27
DK175461B1 (en) 2004-11-01
FI113475B (en) 2004-04-30
IL92470A0 (en) 1990-08-31
IL92470A (en) 1997-01-10
KR0152525B1 (en) 1998-10-01
NO912099L (en) 1991-07-31
JPH04501954A (en) 1992-04-09
DK104991A (en) 1991-05-31
DK104991D0 (en) 1991-05-31
JP3085704B2 (en) 2000-09-11
FI912635A0 (en) 1991-05-31
ZA899150B (en) 1991-04-24

Similar Documents

Publication Publication Date Title
DK40591A (en) THREE-DIMENSIONAL CELL AND TISSUE CULTURE SYSTEM
MX163651B (en) ELECTROCHEMICAL CELL
DK38989D0 (en) DNA sequence
FI87937C (en) ELEKTROLYTISK CELL
FI891201L (en) ELECTROCHEMICAL CELL.
FI893497A0 (en) ELEKTROKEMISK CELL MED DUBBELVERKANDE ELEKTROD.
DK440289A (en) FUEL CELL
DK261790A (en) MARINE CELL
DK109590A (en) BIOLOGICAL ACTIVE PROTEIN
FI880636A0 (en) FOERFARANDE FOER INAKTIVERING AV MED HOELJE FOERSEDDA VIRUS I EN MEDELST EN CELL IN VITRO FRAMSTAELLDA PROTEINPRODUKTER.
KR910700344A (en) HIV protein expression in Drosophila cells
PT86588A (en) KASSETTEN-VEKTOR-SYSTEM ZUR EXPRESSION OFFENER LESERAHMEN IN EUKARYOTICHEN ZELLEN
NO891715D0 (en) EXPRESSION OF INTERFERON-8 IN METYLOTROPHIC YEARS.
FI881648A0 (en) in shampoo
DK578189D0 (en) DNA sequence
NO910787D0 (en) THREE-DIMENSIONAL CELL AND TISSUE CULTURE SYSTEM.
IE893803L (en) Expression of hiv proteins in drosophila cells
BR8905603A (en) STRUCTURE IN TRELICA
NO169999C (en) cross country
TR23461A (en) SUEBSTITUEE INOLAZOLS IN INSEKTISID OEZELIK
KR900004696U (en) Multipurpose knife with viper first aid
BR6801895U (en) PROVISION INTRODUCED IN PROSTHESIS
SE8700550D0 (en) ELD CLASS IN BIOMASS
DK619988D0 (en) ACTIVE PROTEIN
AR240204A1 (en) IMPROVEMENTS IN SALON PETARDITES

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19900801

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19941125

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19900801

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19971014

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980324

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980629

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980624

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20010410

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20020424

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20030417

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20040412

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20050418

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20060509

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20070413

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20080414

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20090415

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20100531

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20110530

Start annual number: 14

End annual number: 14

FPAY Annual fee payment

Payment date: 20120530

Year of fee payment: 15

PR1001 Payment of annual fee

Payment date: 20120530

Start annual number: 15

End annual number: 15

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20131229

Termination category: Expiration of duration